Derm-Biome Adds Dr. Jerry Tan to Its Scientific Advisory Board
The Dermatology Digest
NOVEMBER 25, 2024
Jerry Tan, MD, is joining Derm-Biome Pharmaceuticals, Inc.’s s Scientific Advisory Board.
36 
Follow the Leaders: Osmosis Beauty
Associated Skin Care Professionals
AUGUST 14, 2023
Osmosis uses a unique combination of active ingredients that focuses on three important factors: our pharmaceutical-grade delivery system, because most aging occurs deep within the skin; our patented products that create real changes in the skin; and our unique inside-out approach that triggers collagen/elastin and plumps the volume of the face.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Bakuchiol – Vegan Retinol – What is all the hype about?
First Derm
OCTOBER 28, 2021
Every pharmaceutical and skincare company worth their while has a retinol-containing product in the range, and often multiple formulations. Thus, for people suffering from sensitive skin, contact dermatitis, rosacea, and other such conditions, bakuchiol may well be the only anti-aging alternative available.
Retinol Serum: Is It Safe for Kids and Teens?
First Derm
FEBRUARY 21, 2024
They are associated with the treatment of diseases such as acne, rosacea, psoriasis, and photoaging. Pharmaceutics. In medical practice, retinoids are used to address more severe dermatological concerns, and their prescription and usage are closely monitored by healthcare professionals. Clinical Interventions in Aging.
Rational Combinations in Acne
The Dermatology Digest
MARCH 11, 2024
Del Rosso, DO, a dermatologist in Las Vegas, NV, and the new President of the American Acne and Rosacea Society. Topical clascoterone (Winlevi, Sun Pharma) can be prescribed with other acne drugs to cover the four main pillars of acne pathophysiology, explains James Q.
Oh, What a Year: TDD Looks Back at 2023 in Dermatology
The Dermatology Digest
DECEMBER 15, 2023
Food and Drug Administration (FDA) approval of Verrica Pharmaceuticals Inc’s Ycanth for molluscum contagiosum, which is delivered through a single-use applicator. Harper, MD, the Past-president, American Acne and Rosacea Society. “ Other big news in pediatric dermatology in 2023 included the U.S.
Oh, What a Year: TDD Looks Back at 2023 in Dermatology
The Dermatology Digest
DECEMBER 15, 2023
Food and Drug Administration (FDA) approval of Verrica Pharmaceuticals Inc’s Ycanth for molluscum contagiosum, which is delivered through a single-use applicator. Harper, MD, the Past-president, American Acne and Rosacea Society. “ Other big news in pediatric dermatology in 2023 included the U.S.
Let's personalize your content